Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 78726 - 78750 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Thimerosal	Approved	COX4I1	1327	upregulated	Thimerosal results in increased expression of COX4I1 mRNA	16q24.1	A21035
Thimerosal	Approved	CPEB2	132864	upregulated	Thimerosal results in increased expression of CPEB2 mRNA	4p15.32	A21035
Thimerosal	Approved	CPEB3	22849	upregulated	Thimerosal results in increased expression of CPEB3 mRNA	10q23.32	A24424
Thimerosal	Approved	CPNE3	8895	downregulated	Thimerosal results in decreased expression of CPNE3 mRNA	8q21.3	A21035
Thimerosal	Approved	CPS1	1373	downregulated	Thimerosal results in decreased expression of CPS1 mRNA	2q34	A21035
Thimerosal	Approved	CRCP	27297	downregulated	Thimerosal results in decreased expression of CRCP mRNA	7q11.21	A21035
Thimerosal	Approved	CRYAB	1410	upregulated	Thimerosal results in increased expression of CRYAB mRNA	11q23.1	A24424
Thimerosal	Approved	CS	1431	downregulated	Thimerosal results in decreased expression of CS mRNA	12q13.3	A21035
Thimerosal	Approved	CSPP1	79848	upregulated	Thimerosal results in increased expression of CSPP1 mRNA	8q13.1-q13.2	A21035
Thimerosal	Approved	CTDSPL2	51496	upregulated	Thimerosal results in increased expression of CTDSPL2 mRNA	15q15.3-q21.1	A21035
Thimerosal	Approved	CTNNA1	1495	downregulated	Thimerosal results in decreased expression of CTNNA1 mRNA	5q31.2	A21035
Thimerosal	Approved	CTXN3	613212	upregulated	Thimerosal results in increased expression of CTXN3 mRNA	5q23.2	A21035
Thimerosal	Approved	CYB5R3	1727	downregulated	Thimerosal results in decreased expression of CYB5R3 mRNA	22q13.2	A21035
Thimerosal	Approved	CYB5R4	51167	upregulated	Thimerosal results in increased expression of CYB5R4 mRNA	6q14.2	A21035
Thimerosal	Approved	CYP39A1	51302	upregulated	Thimerosal results in increased expression of CYP39A1 mRNA	6p12.3	A21035
Thimerosal	Approved	CYR61	3491	upregulated	Thimerosal results in increased expression of CYR61 mRNA	1p22.3	A24424
Thimerosal	Approved	DACT3	147906	downregulated	Thimerosal results in decreased expression of DACT3 mRNA	19q13.32	A21035
Thimerosal	Approved	DBN1	1627	downregulated	Thimerosal results in decreased expression of DBN1 mRNA	5q35.3	A21035
Thimerosal	Approved	DCAF13	25879	upregulated	Thimerosal results in increased expression of DCAF13 mRNA	8q22.3	A21035
Thimerosal	Approved	DCAF16	54876	downregulated	Thimerosal results in decreased expression of DCAF16 mRNA	4p15.31	A21035
Thimerosal	Approved	DCAF4	26094	downregulated	Thimerosal results in decreased expression of DCAF4 mRNA	14q24.2	A21035
Thimerosal	Approved	DCAF7	10238	downregulated	Thimerosal results in decreased expression of DCAF7 mRNA	17q23.3	A21035
Thimerosal	Approved	DCC	1630	upregulated	Thimerosal results in increased expression of DCC mRNA	18q21.2	A21035
Thimerosal	Approved	DCUN1D1	54165	upregulated	Thimerosal results in increased expression of DCUN1D1 mRNA	3q26.33	A21035
Thimerosal	Approved	DDX39B	7919	downregulated	Thimerosal results in decreased expression of DDX39B mRNA	6p21.33	A21035

Displaying entries 78726 - 78750 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability